Theres a medical reason to have that conversation. Reviewed by Suki K
Compounded Medication Disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products
"People forget that fat is actually a good thing, Gonsahn-Bollie says
However, this outcome fell short of the anticipated 25% weight reduction, potentially limiting its competitive edge against Eli Lillys ZEPBOUND, which reported up to 20.9% weight loss in the SURMOUNT-1 trial. In the subsequent REDEFINE 2 trial, which focused on adults with obesity or overweight and type 2 diabetes, CagriSema achieved a 15.7% mean weight loss after 68 weeks, compared to 3.1% with placebo
Even though most of these drugs do not cross the blood-brain barrier, brain fog is often one of the first symptoms affected and may be due to improvements in blood flows
Additionally, retatrutide is currently undergoing a phase 3 clinical trial expected to conclude in December 2025, which could further validate its efficacy and safety
